Zimmer Biomet Holdings Inc (ZBH)
108.01
+1.43
(+1.34%)
USD |
NYSE |
Jul 05, 16:00
108.01
0.00 (0.00%)
After-Hours: 16:14
Zimmer Biomet Holdings SG&A Expense (Annual): 2.839B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 2.839B |
December 31, 2022 | 2.762B |
December 31, 2021 | 2.843B |
December 31, 2020 | 2.713B |
December 31, 2019 | 3.344B |
December 31, 2018 | 3.379B |
December 31, 2017 | 3.105B |
December 31, 2016 | 2.945B |
December 31, 2015 | 2.660B |
December 31, 2014 | 1.978B |
December 31, 2013 | 1.882B |
December 31, 2012 | 1.912B |
Date | Value |
---|---|
December 31, 2011 | 1.864B |
December 31, 2010 | 1.766B |
December 31, 2009 | 1.764B |
December 31, 2008 | 1.773B |
December 31, 2007 | 1.490B |
December 31, 2006 | 1.356B |
December 31, 2005 | 1.260B |
December 31, 2004 | 1.19B |
December 31, 2003 | 737.50M |
December 31, 2002 | 546.00M |
December 31, 2001 | 532.80M |
December 31, 2000 | 429.70M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
2.713B
Minimum
2020
3.344B
Maximum
2019
2.900B
Average
2.839B
Median
2023
SG&A Expense (Annual) Benchmarks
Stryker Corp | 7.129B |
ResMed Inc | 874.00M |
Align Technology Inc | 1.703B |
NeuroOne Medical Technologies Corp | 6.926M |
Nutriband Inc | 3.774M |